Amphetamine or Amfetamine(Alpha-Methyl-PHenEThylAMINE), also known as beta-phenyl-isopropylamine
and benzedrine, is a prescription stimulant commonly used to treat Attention-deficit hyperactivity disorder (ADHD) in adults and children. It is
also used to treat symptoms of traumatic brain injury and the daytime drowsiness
symptoms of narcolepsy and chronic fatigue
syndrome. Initially it was more popularly used to diminish the appetite and to control
weight. Brand names of the drugs that contain Amphetamine include Adderall and
Dexedrine. The drug is also used illegally as a recreational club drug and as a performance enhancer. The term "Amphetamine" may also refer to the class of compounds
derived from Amphetamine, often referred to as the Substituted
Amphetamines.
History
Amphetamine was first synthesized in 1887 by Lazar Edeleanu at the University of
Berlin. He named the compound phenylisopropylamine. It was one of a series of compounds related to the plant derivative
ephedrine, which had been isolated from Ma-Huang that same year by Nagayoshi Nagai. No pharmacological use was found for amphetamine until 1927, when pioneer
psychopharmacologist Gordon Alles resynthesized it.[1][2] Alles
was part of a group of researchers looking for an ephedrine substitute. In 1937, it became
available in tablet form. During World War II it was extensively used to combat fatigue and increase alertness in soldiers. After
decades of reported abuse, the FDA banned Benzedrine inhalers, and limited
amphetamines to prescription use in 1965, but illegal use became common. Amphetamine became a schedule II drug in 1970.
The related compound methamphetamine was first synthesized from ephedrine in Japan in
1919 by chemist Akira Ogata via reduction of ephedrine using red phosphorus and iodine. The
German military was notorious for their use of methamphetamine in World War Two. The German pharmaceutical Pervitin is an oral pill of 3mg which was made available in 1938, but by mid-1941 it became a controlled
substance, reportedly because of the amount of time needed for a soldier to rest and recover after use. Military doctors were
then given guidelines on how they should issue it.[citation needed]
In 1997[3] and 1998,[4] researchers at Texas A&M
University reported finding amphetamine and methamphetamine in the foliage of two Acacia
species native to Texas, A. berlandieri and
A. rigidula. Previously, both of these compounds had been thought to be human
inventions.[5]
Chemistry
Amphetamine is a chiral compound. The racemic
mixture can be divided into its optical antipodes: levo- and dextro-amphetamine.
Amphetamine is the parent compound of its own structural class, comprising a broad range of psychoactive derivatives, e.g., MDMA (Ecstasy) and the
N-methylated form, methamphetamine. Amphetamine is a homologue of phenethylamine.
At first, the medical drug came in the racemic salt d, l-amphetamine sulfate (racemic amphetamine contains levo- and
dextro-form in equal amounts). Today, dextroamphetamine sulfate is the predominant form of the drug used;[citation needed] it consists entirely of the
d-isomer. Attention disorders are often treated using Adderall or a generic equivalent, a formulation of mixed amphetamine salts that contain both
d/l-amphetamine and d-amphetamine in the sulfate and saccharate forms mixed to a final ratio of 3 parts
d-amphetamine to 1 part l-amphetamine.
Pharmacology
Amphetamine, both as d-amphetamine (dextroamphetamine) and l-amphetamine (or a
racemic mixture of the two isomers), is believed to exert its effects by binding to the monoamine transporters and increasing
extracellular levels of the biogenic amines dopamine, norepinephrine (noradrenaline) and serotonin. It is hypothesized that
d-amphetamine acts primarily on the dopaminergic systems, while l-amphetamine is comparatively norepinephrinergic
(noradrenergic). The primary reinforcing and behavioral-stimulant effects of amphetamine, however, are linked to enhanced
dopaminergic activity, primarily in the mesolimbic dopamine system.
Amphetamine and other amphetamine-type stimulants principally act to release dopamine into the synaptic cleft. Amphetamine has
been shown to both diffuse through the intracellular membrane and travel via the Dopamine Transporter (DAT) to increase
concentrations of amphetamine in the neuronal terminal. The increased amphetamine concentration releases endogenous stores of
dopamine from Vesicular Monoamine Transporters (VMATs), thereby increasing intra-neuronal concentrations of transmitter. This
increase in concentration effectively reverses transport of dopamine via the (DAT) into the synapse.[6] In addition, amphetamine binds reversibly to the dopamine transporter (DAT) and
blocks the transporter's ability to clear DA from the synaptic space. Amphetamine also acts in this way with norepinephrine
(noradrenaline) and to a lesser extent serotonin.
Research published in the Journal of Pharmacology And Experimental Therapeutics (2007),[7] indicates that amphetamine binds to a group of receptors called TrAce Amine
Receptors (TAAR). TAAR are a newly discovered receptor system which
seems to be affected by a range of amphetamine-like substances called trace amines.
Medicinal use
Along with methylphenidate (Ritalin, Concerta, etc.), amphetamine is one of the
standard treatments for ADHD. Beneficial effects for ADHD can
include improved impulse control, improved concentration, decreased sensory overstimulation, and decreased irritability. These
effects can be dramatic, particularly in young children. The ADHD medication Adderall is composed of four different amphetamine
salts, and Adderall XR is a timed-release formulation of these
same salt forms.
When used within the recommended doses, side-effects like loss of appetite tend to decrease over time. However, amphetamines
last longer in the body than methylphenidate (Ritalin, Concerta, etc.), and tend to have stronger side-effects on appetite and sleep.[citation needed]
Amphetamines are also a standard treatment for narcolepsy, as well as other sleeping
disorders. They are generally effective over long periods of time without producing addiction or physical dependence.
Amphetamines are sometimes used to augment anti-depressant therapy in treatment-resistant depression.
Medical use for weight loss is still approved in some countries, but is regarded as obsolete and dangerous in others.
Performance-enhancing use
Amphetamine is commonly used by college and sometimes high-school students as a study and test-taking aid. Amphetamine
increases energy levels, concentration, and motivation, allowing students to study for an extended period of time, much longer
than one would be capable of doing so on his own. Some students may also take it the day of the test. Most students use it only
during final examinations, but some use it on a much more regular basis, which can lead to psychological and physical
addiction.
Amphetamine is used by some professional athletes for its strong stimulant effect. Energy levels are dramatically increased
and sustained, allowing for more vigorous and longer play. This practice can be extremely dangerous, and some athletes have died
as a result. Amphetamine use was common among Major League Baseball (MLB) athletes and were commonly known by the slang term
"greenies" due to the pills' color. In 2006, MLB banned the use of amphetamines; and the ban is enforced by periodic
drug-testing, with serious consequences if a player tests positive.
Some truck drivers, especially long haul drivers, take amphetamine to combat symptoms of somnolence and to increase their
concentration on driving.
Effects of use
Amphetamines release stores of norepinephrine and dopamine from nerve endings by converting the respective molecular
transporters into open channels. Amphetamine also releases stores of serotonin from
synaptic vesicles when taken in relatively high doses. This effect is more pronounced
in methamphetamine use. Like methylphenidate (Ritalin), amphetamines also prevent the monoamine
transporters for dopamine and norepinephrine
from recycling them (called reuptake inhibition), which leads to increased amounts of dopamine
and norepinephrine in synaptic clefts.
These combined effects rapidly increase the concentrations of the respective neurotransmitters in the synaptic cleft, which promotes nerve
impulse transmission in neurons that have those receptors.
Physical effects
- Short-term physiological effects vary greatly, depending on dosage used and the method in
which the drug is taken. At therapeutic levels, these effects could include decreased
appetite, increased stamina and physical energy, increased (in some cases decreased)
sexual drive/response and in some cases bruxism
(teeth-grinding). When the drug is abused, effects could include involuntary bodily movements, hyperhidrosis, hyperactivity, jitteriness, psychomotor agitation, nausea, itchy, blotchy or greasy skin,
tachycardia, irregular heart rate, hypertension, and
headaches. Fatigue can often follow the dose's
period of effectiveness. Overdose can be treated with chlorpromazine.[8]
- Long-term abuse or overdose effects can include tremor, restlessness, changed sleep patterns,
anxiety and increase in pre-existing anxiety, poor skin condition, hyperreflexia, tachypnea, gastrointestinal narrowing, and
weakened immune system. Fatigue and depression
can follow the excitement stage. Erectile dysfunction, heart problems, stroke, and
liver, kidney and lung damage can result from prolonged abuse. When insufflated, amphetamine can lead to a deterioration of the
lining of the nostrils.
Psychological effects
- Short-term psychological effects of the drug at therapeutic levels could include alertness, euphoria, increased
concentration, rapid talking, increased confidence, and increased social responsiveness. Effects of the drug when abused could
include, nystagmus (eye wiggles), hallucinations, and loss of REM sleep the night after use.
- Long-term amphetamine abuse can induce psychological effects that include insomnia, mental states resembling schizophrenia, aggressiveness (not associated with schizophrenia), addiction or dependence with
accompanying withdrawal symptoms, irritability, confusion, and panic. Chronic and/or extensively-continuous use can lead to
amphetamine psychosis, which causes delusions and paranoia, but this is uncommon when taken as prescribed. The abuse of an
amphetamine is highly addictive, and, with chronic abuse, tolerance develops very quickly. Withdrawal, although not
physiologically threatening, is an unpleasant experience (including paranoia, depression,
difficult breathing, dysphoria, gastric fluctuations and/or pain, and lethargia). This commonly leads chronic users to re-dose amphetamine frequently, explaining tolerance
and increasing the possibility of addiction.
Addiction
Tolerance is developed rapidly in amphetamine abuse, therefore increasing the amount
of the drug that is needed to satisfy the addiction.[9]
Many abusers will repeat the amphetamine cycle by taking more of the drug during the withdrawal. This leads to a very dangerous cycle and may involve the use of other drugs to get over the
withdrawal process. Chronic abusers of amphetamines typically snort or resort to drug injection to experience the full effects of
the drug in a faster and more intense way, with the added risks of infection, vein damage, and higher risk of overdose. While
continuous dosing with amphetamine causes tolerance, intermittent use can produce
"reverse tolerance" or sensitization to some psychological effects.[10][11][12][13][14] As a result, regular
use commonly results in a quick decrease of unwanted side-effects, but without an equivalent loss of its stimulant properties. As
a note, the sensitization is induced more quickly, and persists far longer than withdrawal-related effects, suggesting a
phenomenon more complex than a simple tolerance-induced withdrawal syndrome.
Because of the abuse of amphetamines in the U.S., most brands were discontinued by the 1990s, including the highly-abused
brand names Biphetamine (known as black beauties) and Preludin known on the street as Bams, whose coating was peeled and then
injected. Only a few brands of amphetamines are still produced in the United States: those prescribed for narcolepsy,
attention-deficit hyperactivity disorder, treatment-resistant depression, and extreme obesity.[citation needed]
Harm reduction approach to amphetamine use
Proponents of the harm reduction philosophy seek to minimize the harms that arise from
the recreational use of amphetamines. Safer means of taking the drug — smoked, nasal, oral, and rectal — are encouraged due to
the lower risk of overdose, infection, and contraction of bloodborne viruses associated with drug injection. Smoking drugs reveals their effects roughly as fast as injection, as blood directly picks
up the drug at the lungs. Amphetamine, in contrast to methamphetamine, is not smokable.
Where the strength of the drug is unknown, users are encouraged to try a small amount first to gauge the strength, to minimize
the risks of overdose. For the same reason, the use of two or more drugs at the one time is discouraged. Users are also
discouraged from using amphetamines by themselves, as friends can assist in the event of an overdose or amphetamine
psychosis.
Amphetamine users that choose to inject should always use new needles and syringes where possible, and not share these with
other users. Governments that support a harm-reduction approach often supply new needles and syringes on a confidential basis, as
well as education on proper filtering prior to injection, safer injection techniques, and safe disposal of used injecting
gear.
Legal issues
- In the United Kingdom, amphetamines were regarded as Class B drugs. The
maximum penalty for unauthorised possession is five years in prison and an unlimited fine. The maximum penalty for illegal supply
is fourteen years in prison and an unlimited fine.Methamphetamine has recently been reclassified to Class A, penalties for possession of which are more severe (7 years in prison and an unlimited
fine).[15]
- In the United States, amphetamine and methamphetamine are Schedule II
drugs, classified as CNS (Central Nervous System) Stimulants.[16] A Schedule II drug is classified as one that has a high potential for abuse, has a
currently-accepted medical use and is used under severe restrictions, and has a high possibility of severe psychological and
physiological dependence.
On the international scene, amphetamine is a Schedule II drug under the Convention on Psychotropic Substances.[17]
A chart comparing the chemical structures of different
amphetamine derivatives
Books
- Seabrook, Jeremy (1996). In the Cities of the
South: scenes from a developing world. London; New York: Verso. ISBN 1-85984-986-5.
Related pages
References and Notes
- ^ Shulgin, Alexander; Shulgin, Ann (1992). "6 – MMDA",
PiHKAL. Berkeley, California: Transform Press, 39. ISBN 0-9630096-0-5.
- ^ (April 2005) "meth – Anatomy of a
designer drug". Massey University Alumni Magazine (18): 12. Retrieved on 2007-06-23.
“But amphetamine's pharmacological potential was missed, and the molecule lapsed into obscurity until 1927, when it was
resynthesised by Gordon Alles, one of a group of chemists looking for an ephedrine substitute. Alles also prepared amphetamine in
a volatile form. In 1932 it became available under the brand name Benzedrine as an over-the-counter inhaler to treat respiratory
problems – and the contents were widely used for purposes other than the treatment of respiratory disorders.”
- ^ Clement, Beverly A., Goff, Erik Allen Burt, Christina M. and Forbes, T.
David A. (1997). Toxic amines and alkaloids from Acacia berlandieri. Phytochemistry 46(2), pp 249-254
- ^ Clement, Beverly A., Goff, Christina M. and Forbes, T. David A. (1998).
Toxic amines and alkaloids from Acacia rigidula. Phytochemistry 49(5), pp 1377-1380
- ^ Ask Dr. Shulgin Online: Acacias and Natural Amphetamine
- ^ Sulzer, D., (2005). Mechanisms of neurotransmitter release by amphetamines:
A review. Progress in Neurobiology, 75(6);406-433.
- ^ jpet.aspetjournals.org
- ^ rxlist.com
- ^ Amphetamines: Drug Use and Abuse: Merck Manual Home Edition (html). Merck. Retrieved on
February 28, 2007.
- ^ Leith N, Kuczenski R (1981). "Chronic
amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug. some people often resort to
strange ways of using amphetamines, including inserting it into the rectum, which helps the drug enter the blood stream faster
and more effectively, and mixing it with drinks like tea and coffee.". Pharmacol Biochem Behav 15 (3): 399-404.
PMID 7291243.
- ^ Chaudhry I, Turkanis S, Karler R (1988).
"Characteristics of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice.". Neuropharmacology
27 (8): 777-81. PMID 3216957.
- ^ http://www.acnp.org/g4/GN401000166/CH162.htm#SSAT
- ^ Sax KW, Strakowski SM (2001). "Behavioral
sensitization in humans". J Addict Dis. 20 (3): 55-65. PMID 11681593.
- ^ I. Boileau, A. Dagher, M. Leyton, R. N.
Gunn, G. B. Baker, M. Diksic and C. Benkelfat (2006). "[http://archpsyc.ama-assn.org/cgi/content/abstract/63/12/1386 Modeling Sensitization to
Stimulants in Humans: An [11C]Raclopride/Positron Emission Tomography Study in Healthy Men]". Arch
Gen Psychiatry 63 (12): 1386-1395.
- ^
- ^ Trends in Methamphetamine/Amphetamine Admissions to Treatment: 1993-2003 (html). Substance
Abuse and Mental Health Services Administration. Retrieved on February 28, 2007.
- ^ List of psychotropic substances under international control (PDF). International Narcotics Control Board.
Retrieved on November 19, 2005.
External links
|
Amphetamines (N06BA) |
| Amphetamine/dl-Amphetamine, Dextroamphetamine, Dextromethamphetamine, Levomethamphetamine, 4-FMP, 4-MTA, Benzphetamine, Ethylamphetamine, Propylamphetamine, MDMA, MDA, MDEA, Parahydroxyamphetamine, Paramethoxyamphetamine, Paramethoxymethamphetamine,
Paramethoxyethylamphetamine, Xylopropamine |